Volume 77, Issue 5 pp. 628-633
Original Article: Gastroenterology: Inflammatory Bowel Disease

Fatigue and Physical Activity Patterns in Children With Inflammatory Bowel Disease

Nanja Bevers MD

Corresponding Author

Nanja Bevers MD

Department of Pediatrics, Zuyderland Medical Center, Sittard-Geleen, the Netherlands

Address correspondence and reprint requests to Nanja Bevers, MD, Department of Pediatrics, Zuyderland Medical Center, 6162 BG Sittard-Geleen, the Netherlands (e-mail: [email protected]).Search for more papers by this author
Els Van de Vijver MD, PhD

Els Van de Vijver MD, PhD

Department of Paediatric Gastroenterology, Hepatology and Nutrition, Antwerp University Hospital, Edegem, Belgium

Search for more papers by this author
Adrienne Hanssen MSc

Adrienne Hanssen MSc

Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands

Search for more papers by this author
Arta Aliu MD

Arta Aliu MD

Department of Gastroenterology-Hepatology and NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands

Search for more papers by this author
Saskia Vande Velde MD, PhD

Saskia Vande Velde MD, PhD

Department of Paediatric Gastroenterology, Hepatology and Nutrition, Ghent University Hospital, Ghent University, Ghent, Belgium

Search for more papers by this author
Ella Roelant MSc

Ella Roelant MSc

Department of Statistics, Antwerp University Hospital, Edegem, Belgium

Search for more papers by this author
Ashkan Rezazadeh Ardabili MD

Ashkan Rezazadeh Ardabili MD

Department of Gastroenterology-Hepatology and NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands

Search for more papers by this author
Philippe Rosias MD, PhD

Philippe Rosias MD, PhD

Department of Pediatrics, Zuyderland Medical Center, Sittard-Geleen, the Netherlands

Search for more papers by this author
Janneke Stapelbroek MD, PhD

Janneke Stapelbroek MD, PhD

Department of Paediatrics, Catharina Hospital, Eindhoven, the Netherlands

Search for more papers by this author
Imke Bertrams Maartens MD

Imke Bertrams Maartens MD

Department of Paediatrics, Máxima Medical Center, Veldhoven, the Netherlands

Search for more papers by this author
Cathelijne van de Feen MD

Cathelijne van de Feen MD

Department of Paediatrics, Jeroen Bosch Medical Center, Den Bosch, the Netherlands

Search for more papers by this author
Johanna Escher MD, PhD

Johanna Escher MD, PhD

Department of Paediatric Gastroenterology, Erasmus Medical Center, Sophia Children's Hospital, Rotterdam, the Netherlands

Search for more papers by this author
Annemarie Oudshoorn MD

Annemarie Oudshoorn MD

Department of Paediatrics, Gelre Hospital, Apeldoorn, the Netherlands

Search for more papers by this author
Sarah Teklenburg-Roord MD, PhD

Sarah Teklenburg-Roord MD, PhD

Department of Paediatrics, Isala Hospital, Zwolle, the Netherlands

Search for more papers by this author
Anita Vreugdenhil MD, PhD

Anita Vreugdenhil MD, PhD

Department of Paediatric Gastroenterology and NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands

Search for more papers by this author
Marie Pierik MD, PhD

Marie Pierik MD, PhD

Department of Gastroenterology-Hepatology and NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands

Search for more papers by this author
Patrick van Rheenen MD, PhD

Patrick van Rheenen MD, PhD

Department of Paediatric Gastroenterology Hepatology and Nutrition, University of Groningen, University Medical Centre Groningen – Beatrix Children's Hospital, Groningen, the Netherlands

Search for more papers by this author
First published: 26 July 2023
Citations: 4

Dr Pierik reports grants and nonfinancial support from Falk Pharma, grants from European commission, grants from ZONMW (Dutch national research fund), grants and nonfinancial support from Takeda, grants and nonfinancial support from Johnson and Johnson, grants and nonfinancial support from AbbVie, nonfinancial support from Ferring, nonfinancial support from Immunodiagnostics, and nonfinancial support from MSD, all outside the submitted work. The remaining authors report no conflicts of interest.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal's Web site (www.jpgn.org).

Sources of Funding: This work was supported through an unrestricted grant from Vifor Pharma, Glattbrugg, Switzerland; they had no role in the design nor in the collection, analysis, and interpretation of data, the writing of the report, or the decision to submit the paper for publication.

Abstract

Objectives:

Fatigue is a common symptom in children with inflammatory bowel disease (IBD). Diagnostic tests to evaluate biological causes of fatigue commonly include markers of inflammation and hemoglobin (Hb), yet functional parameters have been inadequately studied in pediatric IBD. In this study, we compared fatigued and non-fatigued children with IBD from both a biological and functional point of view.

Methods:

A cross-sectional study of 104 pediatric IBD patients with mild to moderately active IBD was conducted. Fatigued children were defined as those with a Pediatric Quality of Life Inventory Multidimensional Fatigue Scale z score <−2.0. Non-fatigued children had a z score ≥−2.0. Disease-specific quality of life (measured with IMPACT-III score), C-reactive protein (CRP), fecal calprotectin (FC), hemoglobin z score (Hb z score), and physical activity tests including 6-minute walking distance z score (6MWD z score) and triaxial accelerometry (TA) were evaluated.

Results:

Fatigued children (n = 24) had a significant lower IMPACT-III score than non-fatigued children (n = 80). Hb z scores, CRP, FC, and 6MWD z scores were not significantly different between groups. TA was performed in 71 patients. Wear time validation requirements were met in only 31 patients. Fatigued patients spent significant shorter median time in moderate-to-vigorous activity than non-fatigued patients (18.3 vs 37.3 minutes per day, P = 0.008).

Conclusion:

Biological parameters did not discriminate fatigued from non-fatigued patients. TA possibly distinguishes fatigued from non-fatigued patients; the potential association may provide a target for interventions to combat fatigue and improve quality of life.

Graphical Abstract

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.